These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 1719060)
21. The effects of IL-4 on human natural killer cells. A potent regulator of IL-2 activation and proliferation. Nagler A; Lanier LL; Phillips JH J Immunol; 1988 Oct; 141(7):2349-51. PubMed ID: 3262658 [TBL] [Abstract][Full Text] [Related]
22. Recombinant interferons or interleukin-2 increase cytotoxicity by human monocytes and NK cells. Frey JR; Kamber M; Peck R Lymphokine Res; 1987; 6(3):215-27. PubMed ID: 3114569 [TBL] [Abstract][Full Text] [Related]
23. Enhancement of human natural killer cell function by the combined effects of tumor necrosis factor alpha or interleukin-1 and interferon-alpha or interleukin-2. Ostensen ME; Thiele DL; Lipsky PE J Biol Response Mod; 1989 Feb; 8(1):53-61. PubMed ID: 2493514 [TBL] [Abstract][Full Text] [Related]
24. In vivo effects of recombinant human interleukin 2 on antitumor and antiviral natural immunity in induced or natural murine immunodeficiency states. Butler LD; Browne CP; Layman NK; Riedl P; Tang J; Marder P; DeLong D; Manetta J; Bobbitt L; Strnad J Cancer Res; 1988 Nov; 48(21):6081-9. PubMed ID: 3048654 [TBL] [Abstract][Full Text] [Related]
25. Murine strain variation in the natural killer cell and proliferative responses to the immunostimulatory compound 7-allyl-8-oxoguanosine: role of cytokines. Pope BL; Chourmouzis E; MacIntyre JP; Lee S; Goodman MG Cell Immunol; 1994 Dec; 159(2):194-210. PubMed ID: 7994754 [TBL] [Abstract][Full Text] [Related]
26. Tumor necrosis factor, alone or in combination with IL-2, but not IFN-gamma, is associated with macrophage killing of Mycobacterium avium complex. Bermudez LE; Young LS J Immunol; 1988 May; 140(9):3006-13. PubMed ID: 2834450 [TBL] [Abstract][Full Text] [Related]
27. Regulation of natural killer cytotoxicity by recombinant alpha interferons. Augmentation by IFN-alpha 7, an interferon similar to IFN-alpha J. Platsoucas CD; Fox FE; Oleszak E; Fong K; Nanno M; Ioannides CG; Trotta PP Anticancer Res; 1989; 9(4):849-58. PubMed ID: 2817813 [TBL] [Abstract][Full Text] [Related]
28. Differential modulation of LAK and ADCC functions of natural killer cells from AK-5 tumor-bearing rats by IL-2, IL-12 and IFN-gamma. Muralikrishna K; Varalakshmi C; Khar A Cytokines Cell Mol Ther; 1997 Mar; 3(1):51-8. PubMed ID: 9287244 [TBL] [Abstract][Full Text] [Related]
29. Interplay in vitro between ACTH, beta-endorphin, and glucocorticoids in the modulation of spontaneous and lymphokine-inducible human natural killer (NK) cell activity. Gatti G; Masera RG; Pallavicini L; Sartori ML; Staurenghi A; Orlandi F; Angeli A Brain Behav Immun; 1993 Mar; 7(1):16-28. PubMed ID: 8386029 [TBL] [Abstract][Full Text] [Related]
30. Prothymosin alpha enhances human natural killer cell cytotoxicity: role in mediating signals for NK activity. Cordero OJ; Sarandeses CS; López JL; Nogueira M Lymphokine Cytokine Res; 1992 Oct; 11(5):277-85. PubMed ID: 1467368 [TBL] [Abstract][Full Text] [Related]
31. Regulation of human natural killer cell activity by interferon-gamma: lack of a role in interleukin 2-mediated augmentation. Sayers TJ; Mason AT; Ortaldo JR J Immunol; 1986 Mar; 136(6):2176-80. PubMed ID: 3081640 [TBL] [Abstract][Full Text] [Related]
32. Systemic alkalinization inhibits the ability of flavone acetic acid to augment natural killer activity, induce cytokine gene expression, and synergize with interleukin 2 for the treatment of murine renal cancer. Futami H; Hornung RL; Back TT; Bull R; Gruys E; Wiltrout RH Cancer Res; 1990 Dec; 50(24):7926-31. PubMed ID: 2253233 [TBL] [Abstract][Full Text] [Related]
33. Lung-specific delivery of cytokines induces sustained pulmonary and systemic immunomodulation in rats. Debs RJ; Fuchs HJ; Philip R; Montgomery AB; Brunette EN; Liggitt D; Patton JS; Shellito JE J Immunol; 1988 May; 140(10):3482-8. PubMed ID: 3283235 [TBL] [Abstract][Full Text] [Related]
34. Role of biological response modifiers in immunochemotherapy of solid tumors and retroviral-induced leukemia. Fuggetta MP; D'Onofrio C; Bonmassar E Ann Ist Super Sanita; 1990; 26(3-4):385-95. PubMed ID: 1708953 [TBL] [Abstract][Full Text] [Related]
35. Activation of human natural killer cells by lipopolysaccharide and generation of interleukin-1 alpha, beta, tumour necrosis factor and interleukin-6. Effect of IL-1 receptor antagonist. Conti P; Dempsey RA; Reale M; Barbacane RC; Panara MR; Bongrazio M; Mier JW Immunology; 1991 Aug; 73(4):450-6. PubMed ID: 1833315 [TBL] [Abstract][Full Text] [Related]
36. Effects of systemic recombinant interleukin-2 on natural killer and lymphokine activated killer activity of human tumor infiltrating lymphocytes. Anderson TM; Ibayashi Y; Tokuda Y; Colquhoun SD; Holmes EC; Golub SH Cancer Res; 1988 Mar; 48(5):1180-3. PubMed ID: 3257716 [TBL] [Abstract][Full Text] [Related]
37. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma. Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077 [TBL] [Abstract][Full Text] [Related]
38. Modulation of in vitro porcine natural killer cell activity by recombinant interleukin-1 alpha, interleukin-2 and interleukin-4. Knoblock KF; Canning PC Immunology; 1992 Jun; 76(2):299-304. PubMed ID: 1634252 [TBL] [Abstract][Full Text] [Related]
39. Cytolytic activity of natural killer cells and lymphokine activated killer cells against hepatitis A virus infected fibroblasts. Baba M; Hasegawa H; Nakayabu M; Fukai K; Suzuki S J Clin Lab Immunol; 1993; 40(2):47-60. PubMed ID: 7932628 [TBL] [Abstract][Full Text] [Related]
40. Anti-proliferative effect of IFN-gamma in immune regulation. II. IFN-gamma inhibits the proliferation of murine bone marrow cells stimulated with IL-3, IL-4, or granulocyte-macrophage colony-stimulating factor. Gajewski TF; Goldwasser E; Fitch FW J Immunol; 1988 Oct; 141(8):2635-42. PubMed ID: 2971726 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]